MindMed Announces the start of the First Ever Clinical Trial Measuring and Evaluating MDMA and LSD

If administered in combination with LSD, the company said MDMA may increase positive subjective drug effects, including positive mood and empathy, and reduce the negative emotions and anxiety sometimes associated with LSD Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) announced Wednesday the start of the first-ever clinical trial measuring and evaluating MDMA and LSD used in combination in the human body.
Read more...

;